N+1 Singer is gold sponsor of the OBN Awards Dinner

OBN is a networking organization which supports and brings together the UK’s innovative life sciences companies, corporate partners and investors at various events and functions during the year. The OBN Awards 2017 (5th October in Oxford)

Read More
N+1 Singer sponsors The Sunday Times Tech Track 100

N+1 Singer is a main sponsor of Tech Track 100 for a second year, and an award and dinner sponsor of Fast Track 100 in 2017 and 2018. The Sunday Times Hiscox Tech Track 100 league

Read More
£150.3 million recommended offer for Quantum Pharma by Clinigen Group

N+1 Singer is acting as Rule 3 Adviser, Nominated Adviser and Broker to Quantum Pharma plc. Yesterday, the boards of Quantum and Clinigen announced the terms of a recommended offer to be made by Clinigen to

Read More
N+1 Singer is the exclusive UK broker partner for Auerbach Grayson

Auerbach Grayson is a New York-based brokerage firm committed to serving the international needs of major US institutional investors. They provide direct access to local research and ideas with best execution in over 123 markets worldwide.

Read More
APQ: successful raise of £20.09 million on the International Securities Market

APQ has successfully raised £20.09 million through a placing of convertible unsecured loan stock 2024 (“CULS”) on the International Securities Market, the London Stock Exchange’s market for fixed income securities, to expand its portfolio of investments

Read More
ReNeuron: Appointment of N+1 Singer as Joint Broker

ReNeuron Group plc (the “Company”) (AIM: RENE), a leading UK-based stem cell therapy development company has announced the appointment of Nplus1 Singer Advisory LLP (‘N+1 Singer’) as its joint broker with immediate effect. ReNeuron is a

Read More